HEADER OXIDOREDUCTASE 07-APR-18 6G83 TITLE CRYSTAL STRUCTURE OF M. TUBERCULOSIS DPRE1 IN COMPLEX WITH SPBTZ169 TITLE 2 (SULFONYLPBTZ) COMPND MOL_ID: 1; COMPND 2 MOLECULE: DECAPRENYLPHOSPHORYL-BETA-D-RIBOSE OXIDASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DECAPRENYLPHOSPHO-BETA-D-RIBOFURANOSE 2-DEHYDROGENASE, COMPND 5 DECAPRENYLPHOSPHORYL-BETA-D-RIBOFURANOSE 2'-EPIMERASE SUBUNIT DPRE1, COMPND 6 DECAPRENYL-PHOSPHORIBOSE 2'-EPIMERASE SUBUNIT 1,DECAPRENYLPHOSPHORYL- COMPND 7 BETA-D-RIBOFURANOSE 2'-OXIDASE,DECAPRENYLPHOSPHORYL-BETA-D-RIBOSE 2- COMPND 8 EPIMERASE FLAVOPROTEIN SUBUNIT,FAD-DEPENDENT DECAPRENYLPHOSPHORYL- COMPND 9 BETA-D-RIBOFURANOSE 2-OXIDASE; COMPND 10 EC: 1.1.98.3; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS (STRAIN ATCC 25618 / SOURCE 3 H37RV); SOURCE 4 ORGANISM_TAXID: 83332; SOURCE 5 GENE: DPRE1, RV3790; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DPRE1, M. TUBERCULOSIS, INHIBITOR, COMPLEX, BTZ, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR J.PITON,V.MAKAROV,S.T.COLE REVDAT 4 07-FEB-24 6G83 1 REMARK REVDAT 3 08-MAR-23 6G83 1 SOURCE DBREF SEQADV REVDAT 2 03-OCT-18 6G83 1 JRNL REVDAT 1 01-AUG-18 6G83 0 JRNL AUTH J.PITON,A.VOCAT,A.LUPIEN,C.S.FOO,O.RIABOVA,V.MAKAROV, JRNL AUTH 2 S.T.COLE JRNL TITL STRUCTURE-BASED DRUG DESIGN AND CHARACTERIZATION OF JRNL TITL 2 SULFONYL-PIPERAZINE BENZOTHIAZINONE INHIBITORS OF DPRE1 FROM JRNL TITL 3 MYCOBACTERIUM TUBERCULOSIS. JRNL REF ANTIMICROB. AGENTS V. 62 2018 JRNL REF 2 CHEMOTHER. JRNL REFN ESSN 1098-6596 JRNL PMID 30012754 JRNL DOI 10.1128/AAC.00681-18 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.13_2998: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.18 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 39780 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.400 REMARK 3 FREE R VALUE TEST SET COUNT : 1750 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.1894 - 5.6406 0.99 3023 131 0.1890 0.2222 REMARK 3 2 5.6406 - 4.4781 1.00 2964 138 0.1664 0.1845 REMARK 3 3 4.4781 - 3.9123 0.99 2956 134 0.1670 0.2124 REMARK 3 4 3.9123 - 3.5547 0.99 2931 137 0.1829 0.1922 REMARK 3 5 3.5547 - 3.3000 0.99 2941 139 0.2070 0.2400 REMARK 3 6 3.3000 - 3.1054 0.99 2925 132 0.2130 0.2401 REMARK 3 7 3.1054 - 2.9499 0.99 2928 135 0.2095 0.2336 REMARK 3 8 2.9499 - 2.8215 0.99 2894 137 0.2378 0.2578 REMARK 3 9 2.8215 - 2.7129 0.99 2917 126 0.2334 0.2511 REMARK 3 10 2.7129 - 2.6193 0.99 2906 142 0.2458 0.2792 REMARK 3 11 2.6193 - 2.5374 0.98 2879 127 0.2528 0.2999 REMARK 3 12 2.5374 - 2.4649 0.98 2902 137 0.2737 0.2766 REMARK 3 13 2.4649 - 2.4000 0.98 2864 135 0.2871 0.3114 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.550 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 6557 REMARK 3 ANGLE : 0.945 8954 REMARK 3 CHIRALITY : 0.051 1005 REMARK 3 PLANARITY : 0.006 1143 REMARK 3 DIHEDRAL : 15.761 2275 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6G83 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-APR-18. REMARK 100 THE DEPOSITION ID IS D_1200009563. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JAN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 79124 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 49.180 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.4200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4NCR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.85 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CONTAINING 100 MM IMIDAZOLE, PH 7.2 REMARK 280 -7.5, 18-24 % POLYPROPYLENEGLYCOL 400, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.01200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 LEU A 2 REMARK 465 SER A 3 REMARK 465 VAL A 4 REMARK 465 GLY A 5 REMARK 465 ALA A 6 REMARK 465 THR A 7 REMARK 465 ALA A 269 REMARK 465 PRO A 270 REMARK 465 GLN A 271 REMARK 465 LEU A 272 REMARK 465 LEU A 273 REMARK 465 THR A 274 REMARK 465 LEU A 275 REMARK 465 PRO A 276 REMARK 465 ASP A 277 REMARK 465 VAL A 278 REMARK 465 PHE A 279 REMARK 465 PRO A 280 REMARK 465 ASN A 281 REMARK 465 GLY A 282 REMARK 465 LEU A 283 REMARK 465 LEU A 317 REMARK 465 ASP A 318 REMARK 465 MET A 319 REMARK 465 PHE A 320 REMARK 465 GLY A 321 REMARK 465 GLU A 322 REMARK 465 TRP A 323 REMARK 465 ASN A 324 REMARK 465 ARG A 325 REMARK 465 ALA A 326 REMARK 465 TYR A 327 REMARK 465 GLY A 328 REMARK 465 PRO A 329 REMARK 465 ALA A 330 REMARK 465 MET B -19 REMARK 465 GLY B -18 REMARK 465 SER B -17 REMARK 465 SER B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 SER B -9 REMARK 465 SER B -8 REMARK 465 GLY B -7 REMARK 465 LEU B -6 REMARK 465 VAL B -5 REMARK 465 PRO B -4 REMARK 465 ARG B -3 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 LEU B 2 REMARK 465 SER B 3 REMARK 465 VAL B 4 REMARK 465 GLY B 5 REMARK 465 ALA B 6 REMARK 465 ASP B 268 REMARK 465 ALA B 269 REMARK 465 PRO B 270 REMARK 465 GLN B 271 REMARK 465 LEU B 272 REMARK 465 LEU B 273 REMARK 465 THR B 274 REMARK 465 LEU B 275 REMARK 465 PRO B 276 REMARK 465 ASP B 277 REMARK 465 VAL B 278 REMARK 465 PHE B 279 REMARK 465 PRO B 280 REMARK 465 ASN B 281 REMARK 465 GLY B 282 REMARK 465 LEU B 283 REMARK 465 ALA B 284 REMARK 465 ASN B 285 REMARK 465 LYS B 286 REMARK 465 TYR B 287 REMARK 465 THR B 288 REMARK 465 PHE B 289 REMARK 465 GLY B 290 REMARK 465 PRO B 291 REMARK 465 ILE B 292 REMARK 465 GLY B 293 REMARK 465 GLU B 294 REMARK 465 HIS B 315 REMARK 465 PRO B 316 REMARK 465 LEU B 317 REMARK 465 ASP B 318 REMARK 465 MET B 319 REMARK 465 PHE B 320 REMARK 465 GLY B 321 REMARK 465 GLU B 322 REMARK 465 TRP B 323 REMARK 465 ASN B 324 REMARK 465 ARG B 325 REMARK 465 ALA B 326 REMARK 465 TYR B 327 REMARK 465 GLY B 328 REMARK 465 PRO B 329 REMARK 465 ALA B 330 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 11 OG1 CG2 REMARK 470 ARG A 12 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 18 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 33 CG CD OE1 OE2 REMARK 470 MET A 34 CG SD CE REMARK 470 ARG A 41 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 44 CG CD OE1 OE2 REMARK 470 GLU A 157 CG CD OE1 OE2 REMARK 470 GLU A 166 CG CD OE1 OE2 REMARK 470 TRP A 230 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 230 CZ3 CH2 REMARK 470 GLU A 263 CG CD OE1 OE2 REMARK 470 LYS A 266 CG CD CE NZ REMARK 470 PHE A 267 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP A 268 CG OD1 OD2 REMARK 470 PHE A 289 CG CD1 CD2 CE1 CE2 CZ REMARK 470 TYR A 297 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 299 CG CD CE NZ REMARK 470 HIS A 315 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 334 CG CD OE1 NE2 REMARK 470 PHE A 362 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A 363 CG CD1 CD2 REMARK 470 THR B 8 OG1 CG2 REMARK 470 THR B 11 OG1 CG2 REMARK 470 ARG B 12 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 18 CG CD NE CZ NH1 NH2 REMARK 470 ASN B 25 CG OD1 ND2 REMARK 470 GLU B 33 CG CD OE1 OE2 REMARK 470 LYS B 37 CG CD CE NZ REMARK 470 ARG B 41 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 44 CG CD OE1 OE2 REMARK 470 GLU B 157 CG CD OE1 OE2 REMARK 470 TRP B 230 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 230 CZ3 CH2 REMARK 470 LYS B 259 CG CD CE NZ REMARK 470 LYS B 266 CG CD CE NZ REMARK 470 LEU B 295 CG CD1 CD2 REMARK 470 LYS B 299 CG CD CE NZ REMARK 470 LYS B 306 CG CD CE NZ REMARK 470 LYS B 349 CG CD CE NZ REMARK 470 PHE B 362 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU B 363 CG CD1 CD2 REMARK 470 ASP B 394 CG OD1 OD2 REMARK 470 LYS B 398 CG CD CE NZ REMARK 470 ARG B 421 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 447 CG CD1 CD2 REMARK 470 ARG B 448 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 49 -10.98 68.27 REMARK 500 ASN A 66 74.41 -155.12 REMARK 500 VAL A 175 109.01 -57.45 REMARK 500 THR B 8 91.18 -164.69 REMARK 500 ARG B 18 75.87 49.51 REMARK 500 ALA B 20 68.78 60.59 REMARK 500 SER B 45 32.64 -94.93 REMARK 500 ASP B 130 68.04 36.07 REMARK 500 ALA B 343 47.04 -87.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 632 DISTANCE = 7.87 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FAD A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EQ8 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FAD B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide EQ8 B 502 and CYS B REMARK 800 387 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4NCR RELATED DB: PDB REMARK 900 CONTAINED THE SAME PROTEIN AND TJE CLOSEST DERIVATIVE OF SPBTZ169 DBREF 6G83 A 1 461 UNP P9WJF1 DPRE1_MYCTU 1 461 DBREF 6G83 B 1 461 UNP P9WJF1 DPRE1_MYCTU 1 461 SEQADV 6G83 MET A -19 UNP P9WJF1 INITIATING METHIONINE SEQADV 6G83 GLY A -18 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 SER A -17 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 SER A -16 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 HIS A -15 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 HIS A -14 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 HIS A -13 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 HIS A -12 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 HIS A -11 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 HIS A -10 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 SER A -9 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 SER A -8 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 GLY A -7 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 LEU A -6 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 VAL A -5 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 PRO A -4 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 ARG A -3 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 GLY A -2 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 SER A -1 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 HIS A 0 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 MET B -19 UNP P9WJF1 INITIATING METHIONINE SEQADV 6G83 GLY B -18 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 SER B -17 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 SER B -16 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 HIS B -15 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 HIS B -14 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 HIS B -13 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 HIS B -12 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 HIS B -11 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 HIS B -10 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 SER B -9 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 SER B -8 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 GLY B -7 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 LEU B -6 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 VAL B -5 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 PRO B -4 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 ARG B -3 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 GLY B -2 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 SER B -1 UNP P9WJF1 EXPRESSION TAG SEQADV 6G83 HIS B 0 UNP P9WJF1 EXPRESSION TAG SEQRES 1 A 481 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 481 LEU VAL PRO ARG GLY SER HIS MET LEU SER VAL GLY ALA SEQRES 3 A 481 THR THR THR ALA THR ARG LEU THR GLY TRP GLY ARG THR SEQRES 4 A 481 ALA PRO SER VAL ALA ASN VAL LEU ARG THR PRO ASP ALA SEQRES 5 A 481 GLU MET ILE VAL LYS ALA VAL ALA ARG VAL ALA GLU SER SEQRES 6 A 481 GLY GLY GLY ARG GLY ALA ILE ALA ARG GLY LEU GLY ARG SEQRES 7 A 481 SER TYR GLY ASP ASN ALA GLN ASN GLY GLY GLY LEU VAL SEQRES 8 A 481 ILE ASP MET THR PRO LEU ASN THR ILE HIS SER ILE ASP SEQRES 9 A 481 ALA ASP THR LYS LEU VAL ASP ILE ASP ALA GLY VAL ASN SEQRES 10 A 481 LEU ASP GLN LEU MET LYS ALA ALA LEU PRO PHE GLY LEU SEQRES 11 A 481 TRP VAL PRO VAL LEU PRO GLY THR ARG GLN VAL THR VAL SEQRES 12 A 481 GLY GLY ALA ILE ALA CYS ASP ILE HIS GLY LYS ASN HIS SEQRES 13 A 481 HIS SER ALA GLY SER PHE GLY ASN HIS VAL ARG SER MET SEQRES 14 A 481 ASP LEU LEU THR ALA ASP GLY GLU ILE ARG HIS LEU THR SEQRES 15 A 481 PRO THR GLY GLU ASP ALA GLU LEU PHE TRP ALA THR VAL SEQRES 16 A 481 GLY GLY ASN GLY LEU THR GLY ILE ILE MET ARG ALA THR SEQRES 17 A 481 ILE GLU MET THR PRO THR SER THR ALA TYR PHE ILE ALA SEQRES 18 A 481 ASP GLY ASP VAL THR ALA SER LEU ASP GLU THR ILE ALA SEQRES 19 A 481 LEU HIS SER ASP GLY SER GLU ALA ARG TYR THR TYR SER SEQRES 20 A 481 SER ALA TRP PHE ASP ALA ILE SER ALA PRO PRO LYS LEU SEQRES 21 A 481 GLY ARG ALA ALA VAL SER ARG GLY ARG LEU ALA THR VAL SEQRES 22 A 481 GLU GLN LEU PRO ALA LYS LEU ARG SER GLU PRO LEU LYS SEQRES 23 A 481 PHE ASP ALA PRO GLN LEU LEU THR LEU PRO ASP VAL PHE SEQRES 24 A 481 PRO ASN GLY LEU ALA ASN LYS TYR THR PHE GLY PRO ILE SEQRES 25 A 481 GLY GLU LEU TRP TYR ARG LYS SER GLY THR TYR ARG GLY SEQRES 26 A 481 LYS VAL GLN ASN LEU THR GLN PHE TYR HIS PRO LEU ASP SEQRES 27 A 481 MET PHE GLY GLU TRP ASN ARG ALA TYR GLY PRO ALA GLY SEQRES 28 A 481 PHE LEU GLN TYR GLN PHE VAL ILE PRO THR GLU ALA VAL SEQRES 29 A 481 ASP GLU PHE LYS LYS ILE ILE GLY VAL ILE GLN ALA SER SEQRES 30 A 481 GLY HIS TYR SER PHE LEU ASN VAL PHE LYS LEU PHE GLY SEQRES 31 A 481 PRO ARG ASN GLN ALA PRO LEU SER PHE PRO ILE PRO GLY SEQRES 32 A 481 TRP ASN ILE CYS VAL ASP PHE PRO ILE LYS ASP GLY LEU SEQRES 33 A 481 GLY LYS PHE VAL SER GLU LEU ASP ARG ARG VAL LEU GLU SEQRES 34 A 481 PHE GLY GLY ARG LEU TYR THR ALA LYS ASP SER ARG THR SEQRES 35 A 481 THR ALA GLU THR PHE HIS ALA MET TYR PRO ARG VAL ASP SEQRES 36 A 481 GLU TRP ILE SER VAL ARG ARG LYS VAL ASP PRO LEU ARG SEQRES 37 A 481 VAL PHE ALA SER ASP MET ALA ARG ARG LEU GLU LEU LEU SEQRES 1 B 481 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 481 LEU VAL PRO ARG GLY SER HIS MET LEU SER VAL GLY ALA SEQRES 3 B 481 THR THR THR ALA THR ARG LEU THR GLY TRP GLY ARG THR SEQRES 4 B 481 ALA PRO SER VAL ALA ASN VAL LEU ARG THR PRO ASP ALA SEQRES 5 B 481 GLU MET ILE VAL LYS ALA VAL ALA ARG VAL ALA GLU SER SEQRES 6 B 481 GLY GLY GLY ARG GLY ALA ILE ALA ARG GLY LEU GLY ARG SEQRES 7 B 481 SER TYR GLY ASP ASN ALA GLN ASN GLY GLY GLY LEU VAL SEQRES 8 B 481 ILE ASP MET THR PRO LEU ASN THR ILE HIS SER ILE ASP SEQRES 9 B 481 ALA ASP THR LYS LEU VAL ASP ILE ASP ALA GLY VAL ASN SEQRES 10 B 481 LEU ASP GLN LEU MET LYS ALA ALA LEU PRO PHE GLY LEU SEQRES 11 B 481 TRP VAL PRO VAL LEU PRO GLY THR ARG GLN VAL THR VAL SEQRES 12 B 481 GLY GLY ALA ILE ALA CYS ASP ILE HIS GLY LYS ASN HIS SEQRES 13 B 481 HIS SER ALA GLY SER PHE GLY ASN HIS VAL ARG SER MET SEQRES 14 B 481 ASP LEU LEU THR ALA ASP GLY GLU ILE ARG HIS LEU THR SEQRES 15 B 481 PRO THR GLY GLU ASP ALA GLU LEU PHE TRP ALA THR VAL SEQRES 16 B 481 GLY GLY ASN GLY LEU THR GLY ILE ILE MET ARG ALA THR SEQRES 17 B 481 ILE GLU MET THR PRO THR SER THR ALA TYR PHE ILE ALA SEQRES 18 B 481 ASP GLY ASP VAL THR ALA SER LEU ASP GLU THR ILE ALA SEQRES 19 B 481 LEU HIS SER ASP GLY SER GLU ALA ARG TYR THR TYR SER SEQRES 20 B 481 SER ALA TRP PHE ASP ALA ILE SER ALA PRO PRO LYS LEU SEQRES 21 B 481 GLY ARG ALA ALA VAL SER ARG GLY ARG LEU ALA THR VAL SEQRES 22 B 481 GLU GLN LEU PRO ALA LYS LEU ARG SER GLU PRO LEU LYS SEQRES 23 B 481 PHE ASP ALA PRO GLN LEU LEU THR LEU PRO ASP VAL PHE SEQRES 24 B 481 PRO ASN GLY LEU ALA ASN LYS TYR THR PHE GLY PRO ILE SEQRES 25 B 481 GLY GLU LEU TRP TYR ARG LYS SER GLY THR TYR ARG GLY SEQRES 26 B 481 LYS VAL GLN ASN LEU THR GLN PHE TYR HIS PRO LEU ASP SEQRES 27 B 481 MET PHE GLY GLU TRP ASN ARG ALA TYR GLY PRO ALA GLY SEQRES 28 B 481 PHE LEU GLN TYR GLN PHE VAL ILE PRO THR GLU ALA VAL SEQRES 29 B 481 ASP GLU PHE LYS LYS ILE ILE GLY VAL ILE GLN ALA SER SEQRES 30 B 481 GLY HIS TYR SER PHE LEU ASN VAL PHE LYS LEU PHE GLY SEQRES 31 B 481 PRO ARG ASN GLN ALA PRO LEU SER PHE PRO ILE PRO GLY SEQRES 32 B 481 TRP ASN ILE CYS VAL ASP PHE PRO ILE LYS ASP GLY LEU SEQRES 33 B 481 GLY LYS PHE VAL SER GLU LEU ASP ARG ARG VAL LEU GLU SEQRES 34 B 481 PHE GLY GLY ARG LEU TYR THR ALA LYS ASP SER ARG THR SEQRES 35 B 481 THR ALA GLU THR PHE HIS ALA MET TYR PRO ARG VAL ASP SEQRES 36 B 481 GLU TRP ILE SER VAL ARG ARG LYS VAL ASP PRO LEU ARG SEQRES 37 B 481 VAL PHE ALA SER ASP MET ALA ARG ARG LEU GLU LEU LEU HET FAD A 501 84 HET EQ8 A 502 53 HET FAD B 501 84 HET EQ8 B 502 53 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM EQ8 [2-(4-CYCLOHEXYLSULFONYLPIPERAZIN-1-YL)-4- HETNAM 2 EQ8 OXIDANYLIDENE-6-(TRIFLUOROMETHYL)-1,3-BENZOTHIAZIN-8- HETNAM 3 EQ8 YL]-OXIDANYLIDENE-AZANIUM FORMUL 3 FAD 2(C27 H33 N9 O15 P2) FORMUL 4 EQ8 2(C19 H22 F3 N4 O4 S2 1+) FORMUL 7 HOH *108(H2 O) HELIX 1 AA1 ASP A 31 SER A 45 1 15 HELIX 2 AA2 ASN A 97 LEU A 106 1 10 HELIX 3 AA3 THR A 122 CYS A 129 1 8 HELIX 4 AA4 ASN A 135 GLY A 140 1 6 HELIX 5 AA5 SER A 141 ASN A 144 5 4 HELIX 6 AA6 ASP A 167 VAL A 175 1 9 HELIX 7 AA7 SER A 208 HIS A 216 1 9 HELIX 8 AA8 SER A 217 ASP A 218 5 2 HELIX 9 AA9 GLY A 219 TYR A 224 5 6 HELIX 10 AB1 PRO A 257 ARG A 261 5 5 HELIX 11 AB2 GLY A 290 THR A 302 1 13 HELIX 12 AB3 ASN A 309 HIS A 315 1 7 HELIX 13 AB4 ALA A 343 ALA A 356 1 14 HELIX 14 AB5 GLY A 395 PHE A 410 1 16 HELIX 15 AB6 THR A 416 ASP A 419 5 4 HELIX 16 AB7 THR A 423 TYR A 431 1 9 HELIX 17 AB8 ARG A 433 ASP A 445 1 13 HELIX 18 AB9 SER A 452 LEU A 458 1 7 HELIX 19 AC1 ASP B 31 SER B 45 1 15 HELIX 20 AC2 ASN B 97 LEU B 106 1 10 HELIX 21 AC3 THR B 122 CYS B 129 1 8 HELIX 22 AC4 ASN B 135 GLY B 140 1 6 HELIX 23 AC5 SER B 141 ASN B 144 5 4 HELIX 24 AC6 ASP B 167 VAL B 175 1 9 HELIX 25 AC7 SER B 208 HIS B 216 1 9 HELIX 26 AC8 GLY B 219 TYR B 224 5 6 HELIX 27 AC9 PRO B 257 SER B 262 1 6 HELIX 28 AD1 TRP B 296 THR B 302 1 7 HELIX 29 AD2 LEU B 310 TYR B 314 1 5 HELIX 30 AD3 ALA B 343 SER B 357 1 15 HELIX 31 AD4 GLY B 395 PHE B 410 1 16 HELIX 32 AD5 THR B 416 ASP B 419 5 4 HELIX 33 AD6 THR B 423 TYR B 431 1 9 HELIX 34 AD7 ARG B 433 ASP B 445 1 13 HELIX 35 AD8 SER B 452 LEU B 458 1 7 SHEET 1 AA1 4 THR A 9 LEU A 13 0 SHEET 2 AA1 4 SER A 22 ARG A 28 -1 O ALA A 24 N THR A 11 SHEET 3 AA1 4 LEU A 70 ASP A 73 1 O ASP A 73 N LEU A 27 SHEET 4 AA1 4 ALA A 51 ARG A 54 1 N ARG A 54 O ILE A 72 SHEET 1 AA210 ILE A 158 LEU A 161 0 SHEET 2 AA210 VAL A 146 LEU A 152 -1 N LEU A 151 O ARG A 159 SHEET 3 AA210 ILE A 183 GLU A 190 -1 O THR A 188 N SER A 148 SHEET 4 AA210 LEU A 89 ASP A 93 -1 N ILE A 92 O ALA A 187 SHEET 5 AA210 ILE A 80 ASP A 84 -1 N SER A 82 O ASP A 91 SHEET 6 AA210 ILE B 80 ASP B 84 -1 O ILE B 83 N ILE A 83 SHEET 7 AA210 LEU B 89 ASP B 93 -1 O ASP B 91 N SER B 82 SHEET 8 AA210 ILE B 183 GLU B 190 -1 O ALA B 187 N ILE B 92 SHEET 9 AA210 VAL B 146 LEU B 152 -1 N LEU B 152 O ILE B 183 SHEET 10 AA210 ILE B 158 LEU B 161 -1 O LEU B 161 N MET B 149 SHEET 1 AA3 2 LEU A 110 TRP A 111 0 SHEET 2 AA3 2 THR A 192 PRO A 193 -1 O THR A 192 N TRP A 111 SHEET 1 AA4 8 TYR A 303 GLN A 308 0 SHEET 2 AA4 8 PHE A 199 VAL A 205 -1 N PHE A 199 O GLN A 308 SHEET 3 AA4 8 ALA A 243 LEU A 250 -1 O VAL A 245 N ASP A 204 SHEET 4 AA4 8 TYR A 226 PHE A 231 -1 N SER A 228 O SER A 246 SHEET 5 AA4 8 VAL A 365 PHE A 369 -1 O PHE A 366 N ALA A 229 SHEET 6 AA4 8 GLY A 383 PRO A 391 -1 O ASN A 385 N LYS A 367 SHEET 7 AA4 8 PHE A 332 PRO A 340 -1 N LEU A 333 O PHE A 390 SHEET 8 AA4 8 ARG A 413 LEU A 414 -1 O ARG A 413 N VAL A 338 SHEET 1 AA5 4 THR B 9 LEU B 13 0 SHEET 2 AA5 4 SER B 22 ARG B 28 -1 O SER B 22 N LEU B 13 SHEET 3 AA5 4 LEU B 70 ASP B 73 1 O VAL B 71 N ASN B 25 SHEET 4 AA5 4 ALA B 51 ARG B 54 1 N ARG B 54 O ILE B 72 SHEET 1 AA6 2 LEU B 110 TRP B 111 0 SHEET 2 AA6 2 THR B 192 PRO B 193 -1 O THR B 192 N TRP B 111 SHEET 1 AA7 8 TYR B 303 ASN B 309 0 SHEET 2 AA7 8 TYR B 198 VAL B 205 -1 N PHE B 199 O GLN B 308 SHEET 3 AA7 8 ALA B 243 LEU B 250 -1 O VAL B 245 N ASP B 204 SHEET 4 AA7 8 TYR B 226 PHE B 231 -1 N TRP B 230 O ALA B 244 SHEET 5 AA7 8 VAL B 365 PHE B 369 -1 O PHE B 366 N ALA B 229 SHEET 6 AA7 8 GLY B 383 PRO B 391 -1 O ASN B 385 N LYS B 367 SHEET 7 AA7 8 PHE B 332 PRO B 340 -1 N TYR B 335 O VAL B 388 SHEET 8 AA7 8 ARG B 413 LEU B 414 -1 O ARG B 413 N VAL B 338 LINK SG CYS A 387 N02 EQ8 A 502 1555 1555 1.63 LINK SG CYS B 387 N02 EQ8 B 502 1555 1555 1.63 CISPEP 1 PRO A 237 PRO A 238 0 10.17 CISPEP 2 PRO B 237 PRO B 238 0 3.67 SITE 1 AC1 34 TRP A 16 ILE A 52 ALA A 53 ARG A 54 SITE 2 AC1 34 GLY A 55 LEU A 56 GLY A 57 ARG A 58 SITE 3 AC1 34 SER A 59 TYR A 60 ASN A 63 ALA A 64 SITE 4 AC1 34 MET A 74 ALA A 94 PRO A 116 GLY A 117 SITE 5 AC1 34 VAL A 121 THR A 122 GLY A 124 GLY A 125 SITE 6 AC1 34 ALA A 128 CYS A 129 ILE A 131 HIS A 132 SITE 7 AC1 34 ASN A 178 GLY A 179 GLY A 182 ILE A 184 SITE 8 AC1 34 TYR A 415 ALA A 417 EQ8 A 502 HOH A 631 SITE 9 AC1 34 HOH A 639 HOH A 647 SITE 1 AC2 14 GLY A 117 HIS A 132 GLY A 133 LYS A 134 SITE 2 AC2 14 SER A 228 GLN A 336 VAL A 365 LYS A 367 SITE 3 AC2 14 ASN A 385 CYS A 387 LYS A 418 FAD A 501 SITE 4 AC2 14 HOH A 604 HOH A 615 SITE 1 AC3 31 TRP B 16 ILE B 52 ALA B 53 ARG B 54 SITE 2 AC3 31 GLY B 55 LEU B 56 GLY B 57 ARG B 58 SITE 3 AC3 31 SER B 59 TYR B 60 ASN B 63 ALA B 64 SITE 4 AC3 31 ALA B 94 PRO B 116 GLY B 117 VAL B 121 SITE 5 AC3 31 THR B 122 GLY B 124 GLY B 125 ALA B 128 SITE 6 AC3 31 CYS B 129 ILE B 131 HIS B 132 ASN B 178 SITE 7 AC3 31 GLY B 179 GLY B 182 ILE B 184 TYR B 415 SITE 8 AC3 31 ALA B 417 EQ8 B 502 HOH B 624 SITE 1 AC4 16 GLY B 117 HIS B 132 GLY B 133 LYS B 134 SITE 2 AC4 16 TYR B 314 TYR B 335 GLN B 336 ASN B 364 SITE 3 AC4 16 VAL B 365 LYS B 367 PHE B 369 ASN B 385 SITE 4 AC4 16 ILE B 386 VAL B 388 LYS B 418 FAD B 501 CRYST1 78.164 84.024 81.666 90.00 103.98 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012794 0.000000 0.003186 0.00000 SCALE2 0.000000 0.011901 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012619 0.00000